Concepedia
Statistics
Publications
8
Citations
157
H-Index
Active since
2006
Affiliations
Vertex Pharmaceuticals (United States)(Current)
Takeda (United States)
Merck & Co., Inc., Rahway, NJ, USA (United States)
Janssen (Belgium)
AbbVie (United States)
Adam R. Looker is an author at Vertex Pharmaceuticals (United States) specializing in pharmacy, chemical engineering, and pharmaceutics.
Publications per year
2006–2019
A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies
Chris Barber, Vincent Antonucci, Jens-Christoph Baumann et al. · Regulatory Toxicology and Pharmacology · 2017 · 35 citations
Engineering, Strategy, Process Control +3
Risk Assessment of Potentially Genotoxic Impurities within the Framework of Quality by Design
Adam R. Looker, Michael P. Ryan, Bobbianna J. Neubert-Langille et al. · Organic Process Research & Development · 2010 · 27 citations
Pharmacy, Chemical Engineering, Toxicology +17
New Semi-Automated Computer-Based System for Assessing the Purge of Mutagenic Impurities
Michael J. Burns, Martin A. Ott, Andrew Teasdale et al. · Organic Process Research & Development · 2019 · 25 citations · Full text
Understanding the degradation pathway of a poorly water-soluble drug formulated in PEG-400
Jianmei Kochling, Christopher R. Young, Adam R. Looker et al. · Journal of Pharmaceutical and Biomedical Analysis · 2006 · 19 citations
Pharmacy, Pharmaceutics, Pharmacokinetics +14
Development and Manufacture of the Inosine Monophosphate Dehydrogenase Inhibitor Merimepodib, VX-497
Adam R. Looker, Benjamin J. Littler, Todd A. Blythe et al. · Organic Process Research & Development · 2008 · 18 citations
Life Sciences, Medicinal Chemistry, Pharmacology +12
1–5 of 8